MDGL logo

Madrigal Pharmaceuticals (MDGL) Net income

annual net income:

-$465.89M-$92.26M(-24.69%)
December 31, 2024

Summary

  • As of today (June 23, 2025), MDGL annual net profit is -$465.89 million, with the most recent change of -$92.26 million (-24.69%) on December 31, 2024.
  • During the last 3 years, MDGL annual net income has fallen by -$224.05 million (-92.64%).
  • MDGL annual net income is now -689.08% below its all-time high of $79.09 million, reached on December 31, 2009.

Performance

MDGL Net income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMDGLincome statement metrics

quarterly net income:

-$73.24M-$13.82M(-23.26%)
March 31, 2025

Summary

  • As of today (June 23, 2025), MDGL quarterly net profit is -$73.24 million, with the most recent change of -$13.82 million (-23.26%) on March 31, 2025.
  • Over the past year, MDGL quarterly net income has increased by +$74.30 million (+50.36%).
  • MDGL quarterly net income is now -162.00% below its all-time high of $118.12 million, reached on September 30, 2009.

Performance

MDGL quarterly net income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMDGLincome statement metrics

TTM net income:

-$391.59M+$74.30M(+15.95%)
March 31, 2025

Summary

  • As of today (June 23, 2025), MDGL TTM net profit is -$391.59 million, with the most recent change of +$74.30 million (+15.95%) on March 31, 2025.
  • Over the past year, MDGL TTM net income has increased by +$52.69 million (+11.86%).
  • MDGL TTM net income is now -519.80% below its all-time high of $93.28 million, reached on March 31, 2010.

Performance

MDGL TTM net income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMDGLincome statement metrics

Net income Formula

Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses

MDGL Net income Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-24.7%+50.4%+11.9%
3 y3 years-92.6%-27.3%-58.6%
5 y5 years-455.0%-102.7%-272.9%

MDGL Net income Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-92.6%at low-27.3%+51.8%-58.6%+24.5%
5 y5-year-455.0%at low-102.7%+51.8%-272.9%+24.5%
alltimeall time-689.1%at low-162.0%+51.8%-519.8%+24.5%

MDGL Net income History

DateAnnualQuarterlyTTM
Mar 2025
-
-$73.24M(+23.3%)
-$391.59M(-15.9%)
Dec 2024
-$465.89M(+24.7%)
-$59.42M(-44.5%)
-$465.89M(-10.2%)
Sep 2024
-
-$106.96M(-29.6%)
-$518.67M(+1.6%)
Jun 2024
-
-$151.97M(+3.0%)
-$510.45M(+14.9%)
Mar 2024
-
-$147.54M(+31.5%)
-$444.27M(+18.9%)
Dec 2023
-$373.63M(+26.5%)
-$112.19M(+13.6%)
-$373.63M(+7.6%)
Sep 2023
-
-$98.74M(+15.1%)
-$347.34M(+5.3%)
Jun 2023
-
-$85.80M(+11.6%)
-$329.80M(+4.8%)
Mar 2023
-
-$76.90M(-10.5%)
-$314.73M(+6.6%)
Dec 2022
-$295.35M(+22.1%)
-$85.91M(+5.8%)
-$295.35M(+7.8%)
Sep 2022
-
-$81.20M(+14.8%)
-$273.99M(+7.1%)
Jun 2022
-
-$70.73M(+23.0%)
-$255.90M(+3.7%)
Mar 2022
-
-$57.52M(-10.9%)
-$246.82M(+2.1%)
Dec 2021
-$241.85M(+19.6%)
-$64.55M(+2.3%)
-$241.85M(+2.3%)
Sep 2021
-
-$63.10M(+2.4%)
-$236.42M(+2.2%)
Jun 2021
-
-$61.65M(+17.3%)
-$231.28M(+5.8%)
Mar 2021
-
-$52.55M(-11.1%)
-$218.66M(+8.1%)
Dec 2020
-$202.24M(+140.9%)
-$59.12M(+2.0%)
-$202.24M(+18.4%)
Sep 2020
-
-$57.96M(+18.2%)
-$170.86M(+27.2%)
Jun 2020
-
-$49.02M(+35.7%)
-$134.33M(+27.9%)
Mar 2020
-
-$36.13M(+30.3%)
-$105.00M(+25.1%)
Dec 2019
-$83.95M(+155.9%)
-$27.74M(+29.5%)
-$83.95M(+24.0%)
Sep 2019
-
-$21.43M(+8.8%)
-$67.68M(+23.6%)
Jun 2019
-
-$19.70M(+30.6%)
-$54.77M(+31.9%)
Mar 2019
-
-$15.08M(+31.4%)
-$41.53M(+26.6%)
Dec 2018
-$32.81M(+5.3%)
-$11.47M(+34.8%)
-$32.81M(+10.2%)
Sep 2018
-
-$8.51M(+31.8%)
-$29.78M(+0.5%)
Jun 2018
-
-$6.46M(+1.5%)
-$29.63M(-6.0%)
Mar 2018
-
-$6.36M(-24.6%)
-$31.52M(+1.2%)
Dec 2017
-$31.15M(+18.1%)
-$8.45M(+1.0%)
-$31.15M(+2.3%)
Sep 2017
-
-$8.36M(+0.2%)
-$30.46M(-15.7%)
Jun 2017
-
-$8.35M(+39.1%)
-$36.14M(+17.8%)
Mar 2017
-
-$6.00M(-22.6%)
-$30.67M(+16.2%)
Dec 2016
-$26.39M(+285.5%)
-$7.75M(-44.8%)
-$26.39M(+28.6%)
Sep 2016
-
-$14.05M(+388.3%)
-$20.52M(+148.1%)
Jun 2016
-
-$2.88M(+68.0%)
-$8.27M(-67.2%)
Mar 2016
-
-$1.71M(-9.0%)
-$25.20M(-43.0%)
Dec 2015
-$6.84M(-92.1%)
-$1.88M(+4.6%)
-$44.19M(-29.5%)
Sep 2015
-
-$1.80M(-90.9%)
-$62.66M(-22.5%)
Jun 2015
-
-$19.80M(-4.4%)
-$80.83M(-3.0%)
Mar 2015
-
-$20.71M(+1.7%)
-$83.31M(-3.3%)
Dec 2014
-$86.16M
-$20.35M(+1.9%)
-$86.16M(-4.2%)
Sep 2014
-
-$19.97M(-10.4%)
-$89.97M(-2.8%)
DateAnnualQuarterlyTTM
Jun 2014
-
-$22.29M(-5.4%)
-$92.52M(-0.5%)
Mar 2014
-
-$23.56M(-2.5%)
-$93.02M(+3.1%)
Dec 2013
-$90.19M(+43.6%)
-$24.16M(+7.3%)
-$90.19M(+7.2%)
Sep 2013
-
-$22.52M(-1.2%)
-$84.15M(+9.8%)
Jun 2013
-
-$22.79M(+9.9%)
-$76.63M(+11.9%)
Mar 2013
-
-$20.73M(+14.4%)
-$68.47M(+9.0%)
Dec 2012
-$62.79M(+32.5%)
-$18.12M(+20.9%)
-$62.79M(+13.3%)
Sep 2012
-
-$15.00M(+2.6%)
-$55.41M(+4.3%)
Jun 2012
-
-$14.62M(-2.9%)
-$53.15M(+4.2%)
Mar 2012
-
-$15.05M(+40.1%)
-$51.03M(+7.7%)
Dec 2011
-$47.38M(+26.5%)
-$10.74M(-15.6%)
-$47.38M(+4.2%)
Sep 2011
-
-$12.73M(+1.9%)
-$45.46M(+5.8%)
Jun 2011
-
-$12.50M(+9.7%)
-$42.99M(+8.7%)
Mar 2011
-
-$11.40M(+29.2%)
-$39.56M(+5.6%)
Dec 2010
-$37.47M(-147.4%)
-$8.82M(-14.0%)
-$37.47M(+5.0%)
Sep 2010
-
-$10.26M(+13.1%)
-$35.68M(-138.5%)
Jun 2010
-
-$9.07M(-2.5%)
$92.70M(-0.6%)
Mar 2010
-
-$9.31M(+32.3%)
$93.28M(+17.9%)
Dec 2009
$79.09M(-185.4%)
-$7.04M(-106.0%)
$79.09M(+31.4%)
Sep 2009
-
$118.12M(-1490.5%)
$60.17M(-171.4%)
Jun 2009
-
-$8.49M(-63.8%)
-$84.27M(-14.4%)
Mar 2009
-
-$23.50M(-9.5%)
-$98.47M(+6.3%)
Dec 2008
-$92.62M(+45.9%)
-$25.95M(-1.4%)
-$92.62M(+12.7%)
Sep 2008
-
-$26.32M(+16.0%)
-$82.19M(+16.2%)
Jun 2008
-
-$22.69M(+28.6%)
-$70.74M(+9.2%)
Mar 2008
-
-$17.65M(+13.7%)
-$64.79M(+2.0%)
Dec 2007
-$63.49M(+10.9%)
-$15.52M(+4.4%)
-$63.49M(+5.0%)
Sep 2007
-
-$14.88M(-11.1%)
-$60.46M(+1.6%)
Jun 2007
-
-$16.74M(+2.4%)
-$59.51M(+3.1%)
Mar 2007
-
-$16.36M(+31.0%)
-$57.70M(+2.5%)
Dec 2006
-$57.27M(-16.8%)
-$12.49M(-10.3%)
-$56.27M(-5.1%)
Sep 2006
-
-$13.93M(-6.7%)
-$59.27M(-17.7%)
Jun 2006
-
-$14.93M(0.0%)
-$72.03M(-14.0%)
Mar 2006
-
-$14.93M(-3.6%)
-$83.79M(-3.4%)
Dec 2005
-$68.86M(+49.9%)
-$15.49M(-41.9%)
-$86.72M(+21.7%)
Sep 2005
-
-$26.69M(0.0%)
-$71.23M(+59.9%)
Jun 2005
-
-$26.69M(+49.4%)
-$44.54M(+149.4%)
Mar 2005
-
-$17.86M(+103.9%)
-$17.86M(+103.9%)
Dec 2004
-$45.93M(+64.8%)
-
-
Mar 2004
-
-$8.76M
-$8.76M
Dec 2003
-$27.88M(-22.9%)
-
-
Dec 2002
-$36.15M(+9389.2%)
-
-
Dec 2001
-$381.00K
-
-

FAQ

  • What is Madrigal Pharmaceuticals annual net profit?
  • What is the all time high annual net income for Madrigal Pharmaceuticals?
  • What is Madrigal Pharmaceuticals annual net income year-on-year change?
  • What is Madrigal Pharmaceuticals quarterly net profit?
  • What is the all time high quarterly net income for Madrigal Pharmaceuticals?
  • What is Madrigal Pharmaceuticals quarterly net income year-on-year change?
  • What is Madrigal Pharmaceuticals TTM net profit?
  • What is the all time high TTM net income for Madrigal Pharmaceuticals?
  • What is Madrigal Pharmaceuticals TTM net income year-on-year change?

What is Madrigal Pharmaceuticals annual net profit?

The current annual net income of MDGL is -$465.89M

What is the all time high annual net income for Madrigal Pharmaceuticals?

Madrigal Pharmaceuticals all-time high annual net profit is $79.09M

What is Madrigal Pharmaceuticals annual net income year-on-year change?

Over the past year, MDGL annual net profit has changed by -$92.26M (-24.69%)

What is Madrigal Pharmaceuticals quarterly net profit?

The current quarterly net income of MDGL is -$73.24M

What is the all time high quarterly net income for Madrigal Pharmaceuticals?

Madrigal Pharmaceuticals all-time high quarterly net profit is $118.12M

What is Madrigal Pharmaceuticals quarterly net income year-on-year change?

Over the past year, MDGL quarterly net profit has changed by +$74.30M (+50.36%)

What is Madrigal Pharmaceuticals TTM net profit?

The current TTM net income of MDGL is -$391.59M

What is the all time high TTM net income for Madrigal Pharmaceuticals?

Madrigal Pharmaceuticals all-time high TTM net profit is $93.28M

What is Madrigal Pharmaceuticals TTM net income year-on-year change?

Over the past year, MDGL TTM net profit has changed by +$52.69M (+11.86%)
On this page